- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Remus Pharmaceuticals Limited has informed stakeholders about changes related to its Registrar and Share Transfer Agent (RTA). Following the earlier communication regarding the RTA's name change from Link Intime India Private Limited to MUFG Intime India Private Limited, effective December 31, 2024, the company has now updated the RTA’s domain name and generic email ID. The new domain is https://in.mpms.mufg.com/ and the updated email ID is @in.mpms.mufg.com. This change aims to streamline communications and enhance operational efficiency. Keep an eye on this transition, as it may improve shareholder interactions and administration going forward.